Search
Bay Area based Ridge Bio is using machine learning in the wet lab at large scale, but with a cell free platform, to develop optimized linkers for antibody-drug conjugates and precision enzymes
Co-Founder & CEO Weston Kightlinger describes the advantages of only using a cell's internal machinery rather than the entire cell in their experiments at scale, and how they are using this to help other companies develop more precisely engineered drug candidates.
May 26
.png){kind=logo}